Please enable JavaScript to continue using this application.

Compare $BDTX vs $CRBP | Chartloom

Compare

$BDTX vs $CRBP

Black Diamond Therapeutics Inc · Corbus Pharmaceuticals Holdings Inc

BDTX

Black Diamond Therapeutics Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Compare $BDTX vs $CRBP

Comparing Black Diamond Therapeutics Inc and Corbus Pharmaceuticals Holdings Inc

BDTXBlack Diamond Therapeutics Inc

CRBPCorbus Pharmaceuticals Holdings Inc

BDTXBlack Diamond Therapeutics Inc

Market cap

$105M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

-26.5%

52W performance

-54.1%

FCF yield

-31.3%

CRBPCorbus Pharmaceuticals Holdings Inc

Market cap

$100M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-31.6%

52W performance

-59.9%

FCF yield

-87.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDTX

CRBP

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

BDTX$105M

CRBP$100M

Enterprise Value

BDTX$86M

CRBP$76M

Price

BDTX$1.83

CRBP$5.38

P/E Ratio

BDTXN/A

CRBPN/A

P/S Ratio

BDTX0.00x

CRBP76.49x

EV/Sales

BDTX0.00x

CRBP61.41x

EV/EBITDA

BDTX6.96x

CRBP0.00x

P/B Ratio

BDTX1.13x

CRBP1.16x

P/FCF Ratio

BDTXN/A

CRBPN/A

EV/FCF

BDTX-2.61x

CRBP-0.88x

PEG Ratio

BDTXN/A

CRBPN/A

Forward P/E (NTM)

BDTXN/A

CRBPN/A

Forward P/S (NTM)

BDTXN/A

CRBPN/A

Revenue (TTM)

BDTX$0

CRBP$0

Revenue Growth (YoY)

BDTX-100.0%

CRBPN/A

Forward Rev Growth

BDTX533.3%

CRBP116.0%

Gross Margin (TTM)

BDTX0.0%

CRBP0.0%

Operating Margin (TTM)

BDTX0.0%

CRBP0.0%

EBITDA Margin (TTM)

BDTX0.0%

CRBP0.0%

Net Margin (TTM)

BDTX0.0%

CRBP0.0%

FCF Margin (TTM)

BDTXN/A

CRBPN/A

Net Income (TTM)

BDTX$-43M

CRBP$-102M

FCF (TTM)

BDTX$-33M

CRBP$-87M

EPS (TTM)

BDTX-$0.74

CRBP-$5.25

ROE (TTM)

BDTX-3880.0%

CRBP-8705.0%

ROA (TTM)

BDTX-3047.0%

CRBP-7422.0%

ROIC (TTM)

BDTX-3880.0%

CRBP-8705.0%

Cash

BDTX$19M

CRBP$23M

Debt

BDTX$0

CRBP$0

Net Cash/Debt

BDTX$19M

CRBP$23M

Current Ratio (TTM)

BDTX7.28x

CRBP5.71x

Quick Ratio (TTM)

BDTX6.98x

CRBP5.62x

Debt/Equity (TTM)

BDTX0.00x

CRBP0.00x

Debt/Assets (TTM)

BDTX0.0%

CRBP0.0%

Interest Coverage (TTM)

BDTXN/A

CRBPN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

CRBP0.00x

Beta

BDTX3.41

CRBP2.74

52W Performance

BDTX-54.1%

CRBP-59.9%

YTD Performance

BDTX-26.5%

CRBP-31.6%

% from 52W High

BDTX-63.0%

CRBP-73.8%

% from 52W Low

BDTX14.4%

CRBP4.9%

Asset Turnover (TTM)

BDTX0.00x

CRBP0.01x

FCF Yield (TTM)

BDTX-31.3%

CRBP-87.0%

Earnings Yield (TTM)

BDTX-40.6%

CRBP-102.2%

Dividend Yield (TTM)

BDTXN/A

CRBPN/A

Rule of 40

BDTX-100.0

CRBP0.0

EV/GP/RG

BDTXN/A

CRBPN/A

Ticker research

View BDTX research View CRBP research

Metric	BDTX Black Diamond Therapeutics Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$105M	$100M
Enterprise Value	$86M	$76M
Price	$1.83	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	76.49x
EV/Sales	0.00x	61.41x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	116.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-102M
FCF (TTM)	$-33M	$-87M
EPS (TTM)	-$0.74	-$5.25
ROE (TTM)	-3880.0%	-8705.0%
ROA (TTM)	-3047.0%	-7422.0%
ROIC (TTM)	-3880.0%	-8705.0%
Financial Health
Cash	$19M	$23M
Debt	$0	$0
Net Cash/Debt	$19M	$23M
Current Ratio (TTM)	7.28x	5.71x
Quick Ratio (TTM)	6.98x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	2.74
52W Performance	-54.1%	-59.9%
YTD Performance	-26.5%	-31.6%
% from 52W High	-63.0%	-73.8%
% from 52W Low	14.4%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-31.3%	-87.0%
Earnings Yield (TTM)	-40.6%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View CRBP research

Valuation

P/S Ratio

BDTX

0.00x

CRBP

76.49x

EV/FCF

BDTX

-2.61x

CRBP

-0.88x

Growth & revenue

Revenue Growth TTM

BDTX

-100.0%

Forward Revenue Growth

BDTX

533.3%

CRBP

116.0%

Profitability & performance

Gross Margin

BDTX

0.0%

CRBP

0.0%

ROE

BDTX

-3880.0%

CRBP

-8705.0%

FCF Yield %

BDTX

-31.3%

CRBP

-87.0%

52-Week Performance

BDTX

-54.1%

CRBP

-59.9%

Detailed metrics comparison

BDTX

Black Diamond Therapeutics Inc

CRBP

Corbus Pharmaceuticals Holdings Inc

Market Cap

BDTX$105M

CRBP$100M

Enterprise Value

BDTX$86M

CRBP$76M

Price

BDTX$1.83

CRBP$5.38

P/E Ratio

BDTXN/A

CRBPN/A

P/S Ratio

BDTX0.00x

CRBP76.49x

EV/Sales

BDTX0.00x

CRBP61.41x

EV/EBITDA

BDTX6.96x

CRBP0.00x

P/B Ratio

BDTX1.13x

CRBP1.16x

P/FCF Ratio

BDTXN/A

CRBPN/A

EV/FCF

BDTX-2.61x

CRBP-0.88x

PEG Ratio

BDTXN/A

CRBPN/A

Forward P/E (NTM)

BDTXN/A

CRBPN/A

Forward P/S (NTM)

BDTXN/A

CRBPN/A

Revenue (TTM)

BDTX$0

CRBP$0

Revenue Growth (YoY)

BDTX-100.0%

CRBPN/A

Forward Rev Growth

BDTX533.3%

CRBP116.0%

Gross Margin (TTM)

BDTX0.0%

CRBP0.0%

Operating Margin (TTM)

BDTX0.0%

CRBP0.0%

EBITDA Margin (TTM)

BDTX0.0%

CRBP0.0%

Net Margin (TTM)

BDTX0.0%

CRBP0.0%

FCF Margin (TTM)

BDTXN/A

CRBPN/A

Net Income (TTM)

BDTX$-43M

CRBP$-102M

FCF (TTM)

BDTX$-33M

CRBP$-87M

EPS (TTM)

BDTX-$0.74

CRBP-$5.25

ROE (TTM)

BDTX-3880.0%

CRBP-8705.0%

ROA (TTM)

BDTX-3047.0%

CRBP-7422.0%

ROIC (TTM)

BDTX-3880.0%

CRBP-8705.0%

Cash

BDTX$19M

CRBP$23M

Debt

BDTX$0

CRBP$0

Net Cash/Debt

BDTX$19M

CRBP$23M

Current Ratio (TTM)

BDTX7.28x

CRBP5.71x

Quick Ratio (TTM)

BDTX6.98x

CRBP5.62x

Debt/Equity (TTM)

BDTX0.00x

CRBP0.00x

Debt/Assets (TTM)

BDTX0.0%

CRBP0.0%

Interest Coverage (TTM)

BDTXN/A

CRBPN/A

Net Debt/EBITDA (TTM)

BDTX0.00x

CRBP0.00x

Beta

BDTX3.41

CRBP2.74

52W Performance

BDTX-54.1%

CRBP-59.9%

YTD Performance

BDTX-26.5%

CRBP-31.6%

% from 52W High

BDTX-63.0%

CRBP-73.8%

% from 52W Low

BDTX14.4%

CRBP4.9%

Asset Turnover (TTM)

BDTX0.00x

CRBP0.01x

FCF Yield (TTM)

BDTX-31.3%

CRBP-87.0%

Earnings Yield (TTM)

BDTX-40.6%

CRBP-102.2%

Dividend Yield (TTM)

BDTXN/A

CRBPN/A

Rule of 40

BDTX-100.0

CRBP0.0

EV/GP/RG

BDTXN/A

CRBPN/A

Ticker research

View BDTX research View CRBP research

Metric	BDTX Black Diamond Therapeutics Inc	CRBP Corbus Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$105M	$100M
Enterprise Value	$86M	$76M
Price	$1.83	$5.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	76.49x
EV/Sales	0.00x	61.41x
EV/EBITDA	6.96x	0.00x
P/B Ratio	1.13x	1.16x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.61x	-0.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	533.3%	116.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-43M	$-102M
FCF (TTM)	$-33M	$-87M
EPS (TTM)	-$0.74	-$5.25
ROE (TTM)	-3880.0%	-8705.0%
ROA (TTM)	-3047.0%	-7422.0%
ROIC (TTM)	-3880.0%	-8705.0%
Financial Health
Cash	$19M	$23M
Debt	$0	$0
Net Cash/Debt	$19M	$23M
Current Ratio (TTM)	7.28x	5.71x
Quick Ratio (TTM)	6.98x	5.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.41	2.74
52W Performance	-54.1%	-59.9%
YTD Performance	-26.5%	-31.6%
% from 52W High	-63.0%	-73.8%
% from 52W Low	14.4%	4.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-31.3%	-87.0%
Earnings Yield (TTM)	-40.6%	-102.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BDTX research	View CRBP research